Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature

• Publication date

  2002-01-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/415331aPMID 11797011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

  2002cited by this paper
• Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

  2002cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

  2000cited by this paper
• Use of Major Histocompatibility Complex Class I/Peptide/β2M Tetramers To Quantitate CD8+ Cytotoxic T Lymphocytes Specific for Dominant and Nondominant Viral Epitopes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

  1999cited by this paper
• Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.

  1999cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression

  1999cited by this paper
• Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

  1998cited by this paper
• Use of nonionic block copolymers in vaccines and therapeutics.

  1998cited by this paper
• Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.

  1998cited by this paper
• A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing.

  1997cited by this paper
• Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

  1997cited by this paper
• Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

  1997cited by this paper
• Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.

  1996cited by this paper
• An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys

  1996cited by this paper
• Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

  1995cited by this paper
• Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

  1994cited by this paper
• Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

  1994cited by this paper
• Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

  1994cited by this paper
• Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

  1993cited by this paper
• Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.

  1991cited by this paper

• Comparison of Immune Responses Elicited by Ad5F35-AEgp145 Alone or in Combination with rMVA-AEgp145

  2026cites this paper
• Field-based safety evaluation of rVHSV-GΔTM in aquaculture and verification of vaccine efficacy through freeze-dried prototyping in olive flounder.

  2025cites this paper
• Rewriting the script: gene therapy and genome editing for von Willebrand Disease

  2025cites this paper
• Enhancing vaccine stability in transdermal microneedle platforms

  2025cites this paper
• Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

  2024cites this paper
• Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

  2024cites this paper
• Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model

  2024cites this paper
• Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection

  2024cites this paper
• A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications

  2024cites this paper
• Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution

  2024cites this paper
• Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine.

  2024cites this paper
• Recent advances in CD8+ T cell-based immune therapies for HIV cure

  2023cites this paper
• An Oil-Based Adjuvant Improves Immune Responses Induced by Canine Adenovirus-Vectored Vaccine in Mice

  2023cites this paper
• New developments in treatment of HIV

  2023cites this paper
• Urgency and necessity of Epstein-Barr virus prophylactic vaccines

  2022cites this paper
• Evaluation of the Efficacy of COVID-19 Vaccines (Pfizer, Astra Zeneca, Sinopharm) Using Iraqi Local Samples

  2022cites this paper
• Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program

  2022cites this paper
• Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C

  2022cites this paper
• Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development

  2022cites this paper
• Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens

  2022cites this paper
• A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects.

  2022cites this paper
• Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques

  2021cites this paper
• Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines

  2021cites this paper
• Adenovirus Vectors: Excellent Tools for Vaccine Development

  2021cites this paper
• Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates

  2021cites this paper
• Application of Nanotechnology in the COVID-19 Pandemic

  2021cites this paper
• Elevated Numbers of HIV-Specific Poly-Functional CD8+ T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals

  2021cites this paper
• Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats

  2021cites this paper
• Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases

  2021cites this paper
• Long-Range Cooperative Disassembly and Aging During Adenovirus Uncoating

  2021cites this paper
• Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

  2021cites this paper
• Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis

  2021cites this paper
• Transplantation of IL-1β siRNA-modified bone marrow mesenchymal stem cells ameliorates type II collagen-induced rheumatoid arthritis in rats

  2021cites this paper
• Marked enhancement of neutralizing antibody and IFN-γ T-cell responses by GX-19N DNA booster in mice primed with inactivated vaccine

  2021cites this paper
• Antigen Presentation of mRNA Based and Viral Vector Corona Vaccines

  2021cites this paper
• Treatment Approach, Pharmacological Agents and Vaccines

  2021cites this paper
• Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward

  2021cites this paper
• Animal Models in Human Adenovirus Research

  2021cites this paper
• Retargeting adenoviruses for therapeutic applications and vaccines

  2020cites this paper
• T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

  2020cites this paper
• Advances and applications of vectored vaccines in animal diseases

  2020cites this paper
• Recombinant Adenovirus Expressing Vesicular Stomatitis Virus G Proteins induce both humoral and cell-medicated immune responses in Mice and Goats

  2020cites this paper
• Nonhuman Primate Models for Antimicrobial Drug Discovery

  2020cites this paper
• Una vacuna preventiva frente al VIH. Situación actual y perspectivas

  2020cites this paper
• Capripoxvirus vectors for vaccine development

  2020cites this paper
• CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts

  2020cites this paper
• The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.

  2020cites this paper
• Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure.

  2020cites this paper
• Tissue is the issue: how altruistic people with HIV are changing the HIV tissue reservoir landscape.

  2020cites this paper
• Frontrunners in the race to develop a SARS-CoV-2 vaccine.

  2020cites this paper
• Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines

  2020cites this paper
• Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine.

  2020cites this paper
• A Zigzag but Upward Way to Develop an HIV-1 Vaccine

  2020cites this paper
• Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

  2020cites this paper
• The potential of adenoviral vaccine vectors with altered antigen presentation capabilities

  2019cites this paper
• Chapter 4 Adenoviral Vector-Based Vaccines and Gene Therapies : Current Status and Future Prospects

  2019cites this paper
• Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge Model

  2019cites this paper
• Semi-quantification of antibody-dependent enhancement (ADE) in the uptake of Adenovirus serotype 5 into THP-1 cells.

  2019cites this paper
• Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV

  2019cites this paper
• Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia

  2019cites this paper
• Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus

  2019cites this paper
• HLA-I associated adaptation dampens the CD8 T-cell response in HIV Ad5-vectored vaccine recipients.

  2019cites this paper
• Local Antigen Encounter Is Essential for Establishing Persistent CD8+ T-Cell Memory in the CNS

  2019cites this paper
• Accelerating HIV vaccine development using non-human primate models

  2019cites this paper
• Comparison of Dendritic Cell Activation by Virus-Based Vaccine Delivery Vectors Emphasizes the Transcriptional Downregulation of the Oxidative Phosphorylation Pathway

  2019cites this paper
• A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

  2019cites this paper
• Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation

  2019cites this paper
• Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes.

  2019cites this paper
• Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection.

  2018cites this paper
• Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects

  2018cites this paper
• Single-cycle adenovirus vectors in the current vaccine landscape

  2018cites this paper
• What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models.

  2018cites this paper
• Nonhuman primate models of human viral infections

  2018cites this paper
• IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses

  2018cites this paper
• Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients

  2018cites this paper
• Advances in HIV-1 Vaccine Development

  2018cites this paper
• What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Reevaluating the Potential of Mouse Models for the Human Immune System.

  2018cites this paper
• Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

  2018cites this paper
• What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.

  2018cites this paper
• Monkey Models and HIV Vaccine Research.

  2018cites this paper
• What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive.

  2018cites this paper
• Willingness to participate in HIV research at the end of life (EOL)

  2018cites this paper
• Lessons learned from HIV antiretroviral treatment interruption trials

  2018cites this paper
• Adenovirus as Tools in Animal Health

  2018cites this paper
• Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer.

  2018cites this paper
• HIV neutralising antibody delivered by gene therapy with a hybrid Vaccinia/retrovirus or BacMam/retrovirus expression systems

  2018cites this paper
• The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

  2018cites this paper
• Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination

  2018cites this paper
• Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles

  2018cites this paper
• Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation

  2017cites this paper
• An investigation of the impact of parasitic worm infection on the immunogenicity of candidate HIV vaccines

  2017cites this paper
• Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.

  2017cites this paper
• Contribution à la recherche d'une stratégie d'immunisation visant à induire une réponse anti-VIH-1 largement neutralisante

  2017cites this paper
• Vaccines for prevention of HIV infection

  2017cites this paper
• Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform

  2017cites this paper
• Progress in HIV vaccine development

  2017cites this paper
• Novel Concepts for HIV Vaccine Vector Design

  2017cites this paper
• Dynamics of cytotoxic T-lymphocytes and helper cells in human immunodeficiency virus infection with Hill-type infection rate and sigmoidal CTL expansion

  2017cites this paper
• Defining Kinetic Properties of HIV-Specific CD8+ T-Cell Responses in Acute Infection

  2017influential citation
• Vacunas de ARN: la más prometedora generación de vacunas

  2017cites this paper